Molecular detection of the ruminal bacterium, Butyrivibrio fibrisolvens, in feces from rural residents of southern India

References

• Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 2007; 73: 1073–8
   PubMed Web of Science ®Google Scholar
• Ramakrishna BS. The normal bacterial flora of the human intestine and its regulation. J Clin Gastroenterol 2007; 41((Suppl 1))S2–S6
   Google Scholar
• Serna, A, 4th, Boedeker, EC. Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections. Curr Opin Gastroenterol 2008;24:38–47.
   PubMed Web of Science ®Google Scholar
• Waddell LA, Rajić A, Sargeant J, Harris J, Amezcua R, Downey L, et al. The zoonotic potential of Mycobacterium avium spp. paratuberculosis: a systematic review. Can J Public Health 2008; 99: 145–55
   PubMed Web of Science ®Google Scholar
• Bujanover Y, Peled Y, Gilat T. Is human methane production affected by long-term occupational exposure to a methanogenic flora?. Isr J Med Sci 1986; 22: 16–18
   Google Scholar
• Hespell RB, Kato K, Costerton JW. Characterization of the cell wall of Butyrivibrio species. Can J Microbiol 1993; 39: 912–21
   Web of Science ®Google Scholar
• Ramakrishna BS, Roediger WEW. Bacterial short chain fatty acids: their role in gastrointestinal disease. Dig Dis 1990; 8: 337–45
   PubMed Web of Science ®Google Scholar
• Kanauchi O, Matsumoto Y, Matsumura M, Fukuoka M, Bamba T. The beneficial effects of microflora, especially obligate anaerobes, and their products on the colonic environment in inflammatory bowel disease. Curr Pharm Des 2005; 11: 1047–53
   PubMed Web of Science ®Google Scholar
• Ohkawara S, Furuya H, Nagashima K, Asanuma N, Hino T. Oral administration of Butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of mice. J Nutr 2005; 135: 2878–83
   PubMed Web of Science ®Google Scholar
• Balamurugan R, Janardhan HP, George S, Raghava MV, Muliyil J, Ramakrishna BS. Molecular studies of fecal anaerobic commensal bacteria in acute diarrhea in children. J Pediatr Gastroenterol Nutr 2008; 46: 514–19
   PubMed Web of Science ®Google Scholar
• Koike S, Yoshitani S, Kobayashi Y, Tanaka K. Phylogenetic analysis of fiber-associated rumen bacterial community and PCR detection of uncultured bacteria. FEMS Microbiol Lett 2003; 229: 23–30
   PubMed Web of Science ®Google Scholar
• Rumney CJ, Duncan SH, Henderson C, Stewart CS. Isolation and characteristics of a wheatbran-degrading Butyrivibrio from human faeces. Lett Appl Microbiol 1995; 20: 232–6
   Web of Science ®Google Scholar
• Rafii F, Franklin W, Cerniglia CE. Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora. Appl Environ Microbiol 1990; 56: 2146–51
   PubMed Web of Science ®Google Scholar
• Hespell RB, Whitehead TR. Physiology and genetics of xylan degradation by gastrointestinal tract bacteria. J Dairy Sci 1990; 73: 3013–22
   PubMed Web of Science ®Google Scholar
• Ramsay AG, Scott KP, Martin JC, Rincon MT, Flint HJ. Cell-associated alpha-amylases of butyrate-producing Firmicute bacteria from the human colon. Microbiology 2006; 152: 3281–90
   PubMed Web of Science ®Google Scholar
• Fukuda S, Suzuki Y, Murai M, Asanuma N, Hino T. Isolation of a novel strain of Butyrivibrio fibrisolvens that isomerizes linoleic acid to conjugated linoleic acid without hydrogenation, and its utilization as a probiotic for animals. J Appl Microbiol 2006; 100: 787–94
   Web of Science ®Google Scholar
• Araki Y, Andoh A, Takizawa J, Takizawa W, Fujiyama Y. Clostridium butyricum, a probiotic derivative, suppresses dextran sulfate sodium-induced experimental colitis in rats. Int J Mol Med 2004; 13: 577–80
   PubMed Web of Science ®Google Scholar
• Heselmans M, Reid G, Akkermans LM, Savelkoul H, Timmerman H, Rombouts FM. Gut flora in health and disease: potential role of probiotics. Curr Issues Intest Microbiol 2005; 6: 1–7
   PubMedGoogle Scholar
• Ohkawara S, Furuya H, Nagashima K, Asanuma N, Hino T. Effect of oral administration of Butyrivibrio fibrisolvens MDT-1 on experimental enterocolitis in mice. Clin Vaccine Immunol 2006; 13: 1231–6
   PubMed Web of Science ®Google Scholar
• Ohkawara S, Furuya H, Nagashima K, Asanuma N, Hino T. Effect of oral administration of Butyrivibrio fibrisolvens MDT-1, a gastrointestinal bacterium, on 3-methylcholanthrene-induced tumor in mice. Nutr Cancer 2007; 59: 92–8
   PubMed Web of Science ®Google Scholar